Arrange a consultation about stem cells
Learn more
Get in touch with us today!
Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.
List of uses for stem cells approved by the FamiCord Group’s laboratories:
List of uses for stem cells approved by the FamiCord Group’s laboratories:
Nr.
Source
Source type
Diagnosis
Medical sector
Year of application
Therapy
Country
Age of the recipient
5301
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
52
5302
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
61
5303
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5304
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5305
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5306
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
39
5307
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
52
5308
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5309
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5310
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
40
5311
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5312
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
53
5313
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5314
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5315
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5316
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
56
5317
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5318
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
35
5319
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5320
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5321
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
41
5322
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
60
5323
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5324
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5325
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
63
5326
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5327
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
66
5328
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
57
5329
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5330
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
67
5331
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5332
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
70
5333
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
64
5334
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
66
5335
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
68
5336
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
58
5337
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
59
5338
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
72
5339
Apheresis
Autologous
Multiple Myeloma
Hematology
2019
Standard Therapy
Germany
65
5340
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5341
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
55
5342
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5343
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
14
5344
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5345
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5346
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
75
5347
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
45
5348
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
70
5349
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
72
5350
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
69
5351
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
45
5352
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
40
5353
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
65
5354
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
72
5355
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
50
5356
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
59
5357
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
66
5358
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5359
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
42
5360
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
68
5361
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
65
5362
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
56
5363
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
63
5364
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5365
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
64
5366
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
42
5367
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
68
5368
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5369
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
68
5370
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5371
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
66
5372
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
66
5373
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
67
5374
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
4
5375
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
56
5376
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
66
5377
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
62
5378
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5379
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
61
5380
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
63
5381
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
44
5382
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
45
5383
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
33
5384
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
66
5385
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
65
5386
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
49
5387
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
69
5388
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
71
5389
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
25
5390
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
42
5391
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
46
5392
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Poland
65
5393
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Germany
49
5394
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Germany
66
5395
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Germany
64
5396
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Germany
67
5397
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2019
Standard Therapy
Germany
66
5398
Apheresis
Allogeneic
Myelodysplastic Syndrome – Raeb
Hematology
2019
Standard Therapy
Poland
21
5399
Apheresis
Allogeneic
Myelodysplastic Syndrome – Raeb
Hematology
2019
Standard Therapy
Poland
16
5400
Apheresis
Allogeneic
Myelodysplastic Syndrome; Myeloproliferative Neoplasms Overlap
Hematology
2019
Standard Therapy
Germany
64